Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology Market Cap: 198.38M for Jan. 23, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Agenus, Inc. | 110.53M |
| AIM ImmunoTech, Inc. | 3.648M |
| Perspective Therapeutics, Inc. | 199.23M |
| Protalix Biotherapeutics, Inc. | 168.88M |
| Armata Pharmaceuticals, Inc. | 213.80M |
Market Cap Related Metrics
| PS Ratio | 374.99 |
| Price to Book Value | 4.066 |
| Price | 2.945 |
| Earnings Yield | -26.95% |